Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitch Dowsett

Showing results (11-20 of 359) with videos related to

Pageof 36
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Estrogen receptor: methodology mattersMitch Dowsett
Breast Cancer Research : BCR|January 9, 2009
Introduction to sessions on 'Predicting personal risk for breast cancer'Mitch Dowsett
Clinical Breast Cancer|May 21, 2003
Human epidermal growth factor receptor-2 and hormonal therapies: clinical implicationsAlistair Ring, Mitch Dowsett
Endocrine-Related Cancer|September 7, 2006
Novel concepts for the chemoprevention of breast cancer through aromatase inhibitionAnne Kendall, Mitch Dowsett
Breast (Edinburgh, Scotland)|October 22, 2011
Predicting response to cytotoxic drugs--the endocrine part of the storyAmna Sheri, Mitch Dowsett
Nature Reviews. Clinical Oncology|December 20, 2018
Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancerJuliet Richman, Mitch Dowsett
Breast Cancer Research and Treatment|November 22, 2014
Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesisMitch Dowsett, Elizabeth Folkerd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2019
Estimating Risk of Recurrence for Early Breast Cancer: Integrating Clinical and Genomic RiskMitch Dowsett, Nicholas Turner
Lancet (London, England)|August 2, 2003
New biology of the oestrogen receptorMitch Dowsett, Alan Ashworth
Endocrine-Related Cancer|December 23, 2004
Mechanisms of tamoxifen resistanceAlistair Ring, Mitch Dowsett
Pageof 36

Showing results (11-20 of 359) with videos related to

Sort By:
Pageof 36
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Estrogen receptor: methodology mattersMitch Dowsett
Breast Cancer Research : BCR|January 9, 2009
Introduction to sessions on 'Predicting personal risk for breast cancer'Mitch Dowsett
Clinical Breast Cancer|May 21, 2003
Human epidermal growth factor receptor-2 and hormonal therapies: clinical implicationsAlistair Ring, Mitch Dowsett
Endocrine-Related Cancer|September 7, 2006
Novel concepts for the chemoprevention of breast cancer through aromatase inhibitionAnne Kendall, Mitch Dowsett
Breast (Edinburgh, Scotland)|October 22, 2011
Predicting response to cytotoxic drugs--the endocrine part of the storyAmna Sheri, Mitch Dowsett
Nature Reviews. Clinical Oncology|December 20, 2018
Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancerJuliet Richman, Mitch Dowsett
Breast Cancer Research and Treatment|November 22, 2014
Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesisMitch Dowsett, Elizabeth Folkerd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2019
Estimating Risk of Recurrence for Early Breast Cancer: Integrating Clinical and Genomic RiskMitch Dowsett, Nicholas Turner
Lancet (London, England)|August 2, 2003
New biology of the oestrogen receptorMitch Dowsett, Alan Ashworth
Endocrine-Related Cancer|December 23, 2004
Mechanisms of tamoxifen resistanceAlistair Ring, Mitch Dowsett
Pageof 36